Kamada (KMDA) Receivables (2012 - 2026)
Kamada's (KMDA) quarterly Receivables came in at $40.7 million in Q1 2026, up 19.94% YoY from $33.9 million in Q1 2025, and up 24.46% on a QoQ basis from $32.7 million in Q4 2025.
Kamada (KMDA) Receivables (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Receivables data on file, last reported at $40.7 million in Q1 2026.
- Quarterly Receivables rose 19.94% year-over-year to $40.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.7 million (up 19.94% YoY) and the FY2025 annual result came in at $32.7 million, up 20.56% from the prior year.
- Receivables advanced to $40.7 million in Q1 2026, from $32.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $40.7 million in Q1 2026 to a low of $24528.0 in Q1 2023.
- A 5-year average of $26.1 million and a median of $27.7 million in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables plunged 99.92% — and 2024, when it surged 102908.81%.
- Tracing KMDA's Receivables over 5 years: stood at $27.8 million in 2022, then retreated by 7.03% to $25.8 million in 2023, then advanced by 4.84% to $27.1 million in 2024, then climbed by 20.56% to $32.7 million in 2025, then increased by 24.46% to $40.7 million in 2026.
- The last three Receivables figures came in at $40.7 million (Q1 2026), $32.7 million (Q4 2025), and $35.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Kamada | 465.78 Mn | 436.31 Mn | 22.47 Mn | 36.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.57 Mn |
| Mar 31, 2026 | 40.65 Mn |
| Dec 31, 2025 | 32.66 Mn |
| Sep 30, 2025 | 35.32 Mn |
| Jun 30, 2025 | 35.21 Mn |
| Mar 31, 2025 | 33.89 Mn |
| Dec 31, 2024 | 27.09 Mn |
| Sep 30, 2024 | 20.85 Mn |
| Jun 30, 2024 | 31.17 Mn |
| Mar 31, 2024 | 25.27 Mn |
| Dec 31, 2023 | 25.84 Mn |
| Sep 30, 2023 | 26.76 Mn |
| Jun 30, 2023 | 27.66 Mn |
| Mar 31, 2023 | 24,528.00 |
| Dec 31, 2022 | 27.80 Mn |
| Sep 30, 2022 | 30,881.00 |
| Jun 30, 2022 | 24.15 Mn |
| Mar 31, 2022 | 29.44 Mn |
| Dec 31, 2021 | 44.03 Mn |
| Sep 30, 2021 | 30.94 Mn |